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BEAUTY IS SKIN DEEP: 
THE FASCINATING BIOLOGY OF 
THE EPIDERMIS AND ITS APPENDAGES 
ELAINE FUCHS 
The Howard Hughes Medical Institute, 
Department of Molecular Genetics and Cell Biology, 
The University of Chicago, Chicago, Illinois 
I. INTRODUCTION
T
he skin not only is the largest organ of the body, but it is also the
organ that has received the greatest attention and fascination by man 
and by nature. From the colorful plumage of the peacock to the rainbow 
patterns of the parrotfish and the metallic green spots on the Raja Brooke 
butterfly, nature has clearly had more fun and fancy in creating the surface 
of organisms than she has in those tissues tucked beneath it. From the an­
imal instincts of sexual attraction to the protective role of mimicry to the 
garish colorings designed to keep other organisms at a distance, the mag­
nificence and cleverness displayed in creating body coverings has been not 
only beautiful but also valuable. All cultures have built upon the founda­
tion of nature's imagery, adorning the body with paints and cosmetics, tat­
toos and jewelry. In general, this has been viewed in a positive fashion. But 
there has always been a tension between the body and the mind, resulting 
from the enormous attention given to the skin. As such, the skin has 
gotten a bit of a bad rap: "Beauty is only skin deep," we scoff, "It is our 
hearts, our minds and our souls which matter far more." And yet it is only 
the human who has been able to rationalize away the importance of skin 
in this manner, and, ironically, the mind itself that tempts us to tamper 
with our skin in ways that we so disdain. The fact is that for all organisms, 
the body surface, in all its splendid cloaks, is the source of survival and 
perpetuation. 
47 
The Harvey Lectures, Series 94, pages 47-78 
©2001 Wiley-Liss, Inc. 
48 ELAINE FUCHS 
IL THE MAMMALIAN EPIDERMIS AND THE PROCESS OF 
TERMINAL DIFFERENTIATION 
Since the time when I was a postdoctoral fellow under the supervision 
of Dr. Howard Green, then at the Massachusetts Institute of Technology, 
I began to follow my natural instincts of fascination with the skin to a 
deeper level, one that goes beneath the body surface and into the realm of 
skin biology. I have been interested in understanding the molecular mech­
anisms underlying growth, differentiation, and development in the mam­
malian epidermis and its appendages. The epidermis is the Saran Wrap of 
our body that protects against invasion by harmful microorganisms and 
that prevents essential bodily fluids from evaporating at our body surface 
(Fig. 1). The epidermis thus enables us to exist as terrestrial beings. The 
epidermis must also be able to withstand the various environmental and 
physical traumas to which ·we subject our body surface, survive when we 
wash our hands with soap, and reseal rapidly when we wound our skin. 
How does it accomplish these tasks? 
The epidermis is the epitome of a self-renewing tissue: a single epi­
dermal stem cell has sufficient proliferative capacity to provide enough 
new epidermis to cover the body surface (Rochat et al., 1994). The stem 
cells are tucked away in the innermost, basal layer of the epidermis, which 
is attached to a basement membrane of extracellular matrix. It has been 
postulated that periodically these cells divide asymmetrically to give rise to 
a daughter stem cell and a so-called transit-amplifying cell (Jones and 
Watt, 1993; Jones et al., 1995). The transit-amplifying cell then under­
goes a limited number of divisions in the basal layer before it withdraws 
from the cell cycle, commits to differentiate terminally, detaches from the 
basement membrane, and begins to transit toward the skin surface (Bar­
randon and Green, 1987; for review, see Watt, 1998). As cells reach the 
body surface they are then sloughed, continually being replaced by inner 
cells moving outward. In this fashion the epidermis is normally under a 
constant state of dynamic equilibrium, replenishing itself every two weeks 
throughout life. 
The process of terminal differentiation is morphologically and bio­
chemically complex (Fig. 1). The transition from basal to first suprabasal 
layer is marked by major changes in gene expression, necessary for cells to 
discard their proliferative functions and adopt new protective roles. Genes 
involved in epidermal proliferation are shut off, while genes needed for 
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Fig. 1. The epidermis of mammalian skin. On the left is a schematic representing a 
cross-section of human skin. The areas in pink represent the epithelial components, in­
cluding the epidermis, sebaceous gland, and hair follicle. The diagram at the right illustrates 
the stratified layers of the epidermis, depicting its four major steps in epidermal differentia­
tion: (a) an innermost, basal layer of mitotically active cells, contairting stem cells and transit 
amplifying cells; (b) three to six layers of spinous cells that are still transcriptionally active 
but are no longer dividing; these cells devote most of their translational machinery to ex­
pressing keratins; (c) one to three layers of granular cells chat produce and transiently store 
the components of the lipid barrier; and (d) the stratum corneum, the dead, flattened cells 
held together by the seal of lipids secreted and organized at the end of the terminal differ­
entiation process. (See qilor plates.) 
providing the protective barrier function to the skin surface are turned on. 
Among the first changes are those in keratins, proteins that assemble into 
an extensive cytoskeletal network of 10-nm intermediate filaments, en­
abling epidermal cells to withstand the constant mechanical stresses that 
we subject our skin to daily (Fuchs, 1996; Fuchs and Weber, 1994). In the 
basal layer, keratin filaments composed of KS and K14 are relatively scant 
and dispersed within the cell cytoplasm, imparting a modicum of strength 
to the cells while still enabling them to divide. fu cells enter the suprabasal 
layers, they switch from expression ofK5 and K14 to Kl and KIO (Fuchs 
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and Green, 1980). These new keratins ultimately constitute up to 85% of 
the total protein of the fully differentiated squames that are sloughed from 
the skin surface. The filaments assembled from these keratins aggregate 
into thick cables, forming a durable and dense network. The differentia­
tion process also results in a marked increase and change in the proteins 
that comprise desmosomes, specialized adherens junctions that organize 
the metabolically active layers of the epidermis into a three-dimensional 
lattice of tightly adhering cells (Kowalczyk et al., 1999; Schmidt et al., 
1994). Bundles of keratin filaments span the suprabasal cytoplasm and 
connect to the numerous desmosomal plaques at the plasma membrane, 
giving the cells within these layers the name of "spinous" cells. 
As spinous cells move outward, they enter the granular layer, typified by 
the electron-dense keratohyalin granules composed of filaggrin, a protein 
that when released and processed initiates a dense packing of keratin fila­
ment bundles to form a riearly indestructible protein mass (Dale et al., 
1978; Resing et al., 1993). In the final stages of metabolic activity, two ad­
ditional sets of changes take place. The first is the finishing touches to the 
cornified envelope, a set of proteins that are sequentially synthesized and 
deposited beneath the plasma membrane of the differentiating epidermal 
keratinocytes (Christiano, 1997; Rice and Green, 1979). Loricrin, the last 
and major constituent of the envelope, is made in the granular layer, and 
after a brief storage period in small cytoplasmic granules, it relocalizes to 
the plasma membrane (Candi et al., 1995; Mehrel et al., 1990). As cells 
become permeabilized, an influx in calcium activates epidermal transglu­
taminases, which then through )'-glutamyl E -lysine bonds, chemically 
cross-link the proteins into an indestructible envelope, which also inter­
connects the periphery of the keratin cytoskeleton (Rice and Green, 1979; 
Steinert and Marekov, 1995). Reaching the skin surface, these dead sacs or 
squames are ·packed with dense cytoskeletal forest, impenetrable by chem­
icals, detergents, or other environmental agents that could easily attack the 
cells of our internal organs. 
While the keratin cytoskeleton is important for mechanical strength, it 
does not provide the epidermal barrier to keep microorganisms out and 
essential bodily fluids in. This is accomplished by the late-stage produc­
tion and secretion of specialized lipids, creating a impenetrable seal to the 
skin surface (Downing, 1992; Elias, 1996; Harris et al., 1997; Wertz and 
Downing, 1982). During fetal development in humans, this barrier de­
velops late in pregnancy, at approximately 8.5 months of gestation. Pre-
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maturely born infants lack a lipid barrier and must be placed in an incu­
bator to survive. Much remains to be learned about how this last and yet 
vitally important process of the terminal differentiation pathway is regu­
lated in the skin. 
III. GENETIC DISORDERS OF EPIDERMAL DIFFERENTIATION
In recent years, major advances have been made not only in our under­
standing of the structural changes that take place during terminal �iffer­
entiation in the epidermis, but also in our understanding of what happens 
when this process is defective. My own laboratory's research began by fo­
cusing on the keratins. After studying the process of 10-nm filament as­
sembly, we began to explore whether there might be genetic disorders of 
keratin. Through our studies on the K5 and Kl 4 pair of keratins, we 
learned that most mutations in keratins behave in a dominant negative 
fashion, that is to say that they perturb 10-nm filament assembly even in 
the presence of their wild-type partner keratin (Albers and Fuchs, 1987, 
1989; Coulombe et al., 1990; Letai et al., 1992; Wilson et al., 1992). 
Based on these findings, we predicted that the majority of keratin disor­
ders should display an autosomal dominant pattern of inheritance, and we 
learned which regions of the proteins were most critical to the assembly 
process. 
But what human genetic diseases were likely to be keratin disorders? In 
order to address this question, we used transgenic mouse technology to 
target the expression of a gene encoding a defective keratin to the skin 
(Coulombe et al., 1991a; Vassar et al., 1991). In the first set of experi­
ments, transgenic mice expressing a mutant human keratin 14 gene dis­
played the clinical and pathological features of epidermolysis bullosa 
simplex (EBS), a blistering human skin disorder involving cytolysis or de­
generation of the dividing, that is, basal layer, of the epidermis (Vassar et 
al., 1991) (Table I). Mutant K14 proteins that most severely disrupted 
keratin filament formation displayed more severe skin blistering (Cou­
lombe et al., 1991 a). In the most severe form of the disorder (Dowling 
Meara EBS), aggregates of keratin were present in the basal, but not the 
suprabasal layers of the epidermis. 
The transgenic mice gave us the clues we needed to focus on the human 
form of this disease. We obtained skin biopsies from patient volunteers 
who suffered from EBS. Taking advantage of the remarkable self-renewing 
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TABLE I. CHARACTERISTICS OF EPIDERMOLYSIS BULLOSA SIMPLEX 
Feature Dowling-Meara Koebner Weber-Cockayne 
Autosomal dominant + + + 
Skin blistering Entire body Body Hands/feet 
Basal cell cytolysis + + + 
Discernable abnormalities 
in basal keratin network + + ± 
Keratin clumping 
in basal layer + 
Oral involvement + 
capacity of the epidermis, we cultured epidermal cells from patient volun­
teers who suffered from EBS. Upon cloning and sequencing the K14 and 
KS genes from these keratinocytes, it was soon discovered that humans 
with EBS have point mutations in their K14 or KS genes (Bonifas et al., 
1991; Coulombe et al., 19916; Lane et al., 1992), and that these defects 
reside at chromosomes 17 q 12-21 and 12q 11-12, that is, at the loci of the 
type I and type II keratin gene clusters, respectively (Bonifas et al., 1991; 
Chan et al., 1993, 1994; Rosenberg et al., 1988, 1991). These mutations 
resided in regions that were known to perturb keratin filament assembly. 
The work represented the first example where the genetic basis of a 
human disease had been correctly predicted from transgenic mouse tech­
nology. It also revealed that the function of the keratin network is to im­
part mechanical integrity to cells, without which the cells become fragile 
and prone to rupturing upon mechanical stress. It further led to the cor­
rect prediction that a related disorder, epidermolytic hyperkeratosis (EH) 
would be a genetic disorder involving mutations in Kl and Kl 0: in EH 
patients the basal cells are healthy, but the suprabasal cells of the epidermis 
display cytolysis and perturbations in their keratin networks (Chang et al., 
1992; Chipev et al., 1992; Rothnagel et al., 1992). 
Once the paradigm for a keratin disorder was established, elucidating the 
genetic disorders of keratin became a straightforward process. To date, the 
growing list of keratin disorders has surpassed 10 (Table II) (for review, see 
Fuchs and Cleveland, 1998). This work also led to the realization that there 
are likely to be degenerative disorders involving other members of the in­
termediate filament superfamily. Indeed, aberrations in neurofilament gene 
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TABLE II. DISORDERS OF INTERMEDIATE FILAMENTS AND 
THEIR CYTOSKELETAL NETWORKS 
Genes 
Disorder Cells involved Species mutated 
Epidermolysis bullosa Basal epidermal Mouse/human K5, K14 




EBS w/ mottled Bas. epi. Human K5 
pigmentation 
EBS w/muscular Bas. epi./muscle Human Plectin 
dystrophy 
EBS w/sensory Bas. epi./DRG* Mouse BPAGl 
neuron degeneration 
Junctional epidermolysis Epi./dermal junction Mouse/human a6[34 
bullosa Laminin 5 
Epidermolytic hyper- Suprabasal epi. Mouse/human Kl, KIO 
keratosis (EH) 
lchthyosis bullosa of Upper suprabasal Human KIO, K2e 
Siemens (mild EH) 
Epidermal nevi/EH type Suprabasal epi./mosaic Huipan Kl, KIO 
(mosaic EH) 
Epidermolytic palmo- Suprabasal palmoplantar Human K9 
plantar keratoderma 
Pachyonychia congenita Nails, hair, Mouse/human K6, K16, 
Epidermis near Kl? 
Follicle openings 
White sponge nevus Oral epithelia Human K4, K13 
Esophagus 
Monilethrix Hair Human Ha/Hb 
Keratins 
Chronic hepatitis Liver Mouse K18 
Motor neuron disease Motor neurons Mouse NFs 
Generalized myopathy Muscle Mouse/human Desmin 






















FASCINATING BIOLOGY OF THE EPIDERMIS AND ITS APPENDAGES 55 
expression can lead to motor neuron disease in mice (Cote et al., 1993; Xu 
et al., 1993), and defects in the desmin gene cause generalized muscle de­
generation in mice and in humans (Goldfarb et al., 1998; Li et al., 1996; 
Milner et al., 1996; Munoz-Marmol et al., 1998). 
Epidermal cells are not simply bags of keratin filaments. Rather, keratins 
spin an intricate web of filaments that stretch out across a cell, extending 
from the nuclear envelope in the center of the cell to the desmosomes and 
hemidesmosomes at the cell periphery. As in all stratified squamous ep­
ithelia, the basal layer of the epidermis contains numerous hemidesmo­
somes, which are electron-dense membrane plaques located at the base 
where the epithelium attaches to the basement membrane (Fig. 2A). Fila­
ments composed of laminin 5 anchor hemidesmosomes to the underlying 
basement membrane. At the core of the hemidesmosome is a duster of 
a6!34 integrins, unusual in that they attach to the keratin filament network 
rather than the actin microfilaments (for review, see Garrod, 1993; Jones et 
al., 1998; Schmidt et al., 1994). Three additional proteins, BPAGl-e, 
Fig. 2. Models of cell-substratum and cell-cell junctions in the epidermis. A. Cell­
substratum junctions. Focal contacts and hemidesmosomes are characteristic of all stratified 
squamous epithelia. Focal contacts form around clusters of cdl3 l integrins, whose function 
it is to organize the basement membrane of extracellular matrix to whiduhe epidermis ad­
heres (DiPersio et al., 1997; Hodivala-Dilke et al., 1998). These junctions attach to the actin 
cytoskeleton and are hence likely to be important for epidermal migration and movement. In 
contrast, hemidesmosomes attach to the intermediate filament network. At their core are 
clusters of cx6l34 integrin heterodimers. They are more robust structures, visible at the ultra­
structural level as electron dense membrane plaques. Both cx3l3 l and cx6l34 use laminin 5 as 
their ligand, but the lion's share of cell-substratum adhesion to the basement membrane is 
performed by hemidesmosomes (Dowling et al., 1996; Georges-LaBouesse et al., 1996; Van 
der Neut et al., 1996). B. Cell-cell adhesion. Adherens junctions in epidermal cells are made 
through calcium-activated, homotypic intercellular interactions ofE-cadherins. On the cyto­
plasmic side, these transmembrane domain proteins associate with 13-catenin, which in turn 
associates with cx-catenin and the actin cytoskeleton (for review, see Garrod, 1993; Kowalczyk 
et al., 1999; Schmidt et al., 1994). In contrast, desmosomes associate with the keratin fila­
ment cytoskeleton. At the core of these structures are desmogleins and desmocollins, mem­
bers of the cadherin superfamily. The cytoplasmic domains of these proteins associate with 
plakoglobin and plakophilin 1, members of the 13-catenin superfamily. Desmosomal cad­
herins, plakoglobin, and plakophilin 1 all have the ability biochemically to associate with 
desmoplakin, a homodimeric protein which through its amino terminal domain clusters the 
other desmosomal components, and through its carboxyl terminal domain anchors the in­
termediate filament cytoskeleton (Troyanovsky et al., 1993; Kouklis et al., 1994; Kowalczyk 
et al., 1996; Smith and Fuchs, 1998; Stappenbeck et al., 1993). (See color plates.) 
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BPAG2, and plectin, impart to the hemidesmosome its distinctive struc­
ture. BPAG 1-e is a protein that resides at the inner plate of the hemidesmo­
some where the keratin filaments seem to thread through the inner surface; 
BPAG2 is a transmembrane protein with an extracellular domain similar in 
sequence to secreted collagens. These unusual BPAG proteins receive their 
name from the fact that patients with the autoimmune disease bullous 
pemphigoid produce autoantisera against these proteins (for review, see 
Stanley, 1993). Plectin is a protein that shares sequence similarities with 
BPAG 1-e, but it differs in that it localizes not only to hemidesmosomes but 
also to the keratin cytoskeleton (Wiehe, 1998). 
What is the function of the hemidesmosome? Recently, we used gene 
targeting technology to ablate [34 integrin in mice (Dowling et al., 1996; 
see also Georges-Labouesse, et al., 1996; van der Neut et al., 1996). In the 
absence of [34, a6 is unstable leading to a complete loss of hemidesmo­
somes in these animals. The mice develop clinical signs of a devastating 
human blistering disorder, referred to as junctional epidermolysis bullosa. 
Patients with this disorder have been found to have premature stop codons 
or small internal deletions in either their laminin 5 chains, [34, or a6 
(Vidal et al., 1995; for review, see Christiano and Uitto, 1996; Pulkkinen 
and Uitto, 1998). In our null mice, the complete loss of hemidesmosomes 
leads to a drastic weakening of cell-substratum contacts (Dowling et al., 
1996). These functions seem to be distinct from those of a3f31 integrins, 
which even though present in basal epidermal cells, do not seem able to 
compensate for the loss of a6[34. The a3f31 integrin, which attaches to 
the actin cytoskeleton, appears to play a role in organizing the extracellular 
matrix of the basement membrane (DiPersio et al., 1997). 
What is the function of the attachment of keratin filaments to the 
hemidesmosome? To answer this question, we used gene targeting to ab­
late the BPAG 1 gene in mice (Guo et al., 1995). Removing the coiled-coil 
BPAG 1-e protein from the hemidesmosome severs the connection be­
tween the hemidesmosome and its keratin filament network, leading to a 
narrow zone of mechanical fragility just above the base of these epidermal 
cells (Guo et al., 1995). While the phenotype is somewhat more complex 
due to the plectin's ability to associate with both the actin and keratin cy­
toskeletons, ablation of plectin in mice also results in basal cell fragility 
(Andra et al., 1997). Thus, this attachment of filaments to the base of the 
basal layer appears to protect these cells against the sheer forces exerted 
whenever our skin is rubbed. 
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Keratin filaments are also attached to desmosomes, specialized types of 
cadherin-mediated cell-to-cell junctions that interconnect all cells within 
the epidermis (Fig. 2B; for review, see Kowalczyk et al., 1999; Schmidt et 
al., 1994). While epidermal junctions composed of E-cadherins link to 
the actin cytoskeleton through [3- and a-catenins, those composed of 
desmosomal cadherins link to the keratin cytoskeleton through three po­
tential candidate proteins-desmoplakin, plakoglobin, and plakophilins. 
Based upon recent genetic studies, all three of these proteins appear to be 
involved not only in connecting the keratin filaments to desmosomes, but 
also in desmosome assembly and/ or stabilization. This is perhaps best ex­
emplified by the fact that genetic defects in plakophilin 1 cause congenital 
ectodermal dysplasia, an autosomal recessive human genetic disorder in­
volving suprabasal epidermal degeneration and a loss of cell-cell adhesion 
(McGrath et al., 1997). 
In mice, ablation of the plakoglobin and desmoplakin genes results in 
embryonic lethality. Plakoglobin null embryos die of massive defects in 
the developing heart muscle, whose cells lack desmosomes and intercel­
lular adhesion (Bierkamp et al., 1996; Ruiz et al., 1996). Desmoplakin 
null embryos barely make it past implantation, unable to form an egg cy­
linder, the first major step in developing the shape of the animal (Galli­
cano et al., 1998). In contrast to E-cadherin junctions which are present 
in the two cell mouse embryo and which are necessary for blastocoel 
cavity formation (Ohsugi et al., 1997; Riethmacher et al., 1995; Torres et 
al., 1997), desmosomes first appear in the outer ( trophectoderm) layer of 
the blastocyst and are not found in the inner cells of the developing em­
bryo until gastrulation (Jackson et al., 1981). These findings, coupled 
with their prominent ultrastructure, imply that desmosomes are required 
for processes requiring more robust intercellular adhesion. 
Overall, the phenotypes arising from perturbations in hemidesmosomes 
and desmosomes tells us that the function of these structures is in adher­
ence, in one case to the cell substratum and in the other to intercellular 
connections. In contrast, the connections of these junctions to the keratin 
filament cytoskeleton impart mechanical strength by providing a filamen­
tous framework within the epidermal cells. 
What do we know about the functions of the proteins involved in the 
late stages of terminal differentiation and about their relation to human 
disease? We know that patients who lack transglutaminase 1, the major 
epidermal transglutaminase, do not produce proper cornified envelopes 
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and suffer from lamellar ichthyosis, a disorder typified by generalized 
scaling, hyperkeratosis, and defective barrier function (Candi et al., 1998; 
Huber et al., 1995; Matsuki et al., 1998; Russell, et al., 1995). Patients 
with genetic defects in loricrin suffer from Vohwinkel's syndrome, in­
volving thickening and scaling of the palms and foot soles and constric­
tions of the fingers (Maestrini et al., 1996). Patients with genetic defects 
in steroid sulfatase display the characteristics ofX-linked ichthyosis, where 
the skin surface adopts an appearance of fish scales, and the barrier func­
tion of the epidermis is defective (Shapiro et al., 1978; Webster et al., 
1978; Yen et al.,1987). As we learn more about the molecular pathways 
involved in late-stage epidermal differentiation, additional insights will 
undoubtedly be gained regarding the genetic bases of disorders of the epi­
dermal barrier function. 
IV THE HAlR FOLLICLE: 
THE MAJOR APPENDAGE OF THE EPIDERMIS 
Far less is known about the structure of the hair follicle than the epi­
dermis. A major reason for this is due to the complexity of the follicle. 
Early in development, the epithelium begins as the ectoderm, a single 
layer of cells that are pluripotent and can give rise to either follicle or epi­
dermis. The decision-making process depends upon whether the ectoderm 
makes contact with a condensate of specialized mesenchyme, called the 
dermal papillae. A mesenchymal signal cues an ectodermal cell to prolif­
erate and grow downward to form a hair germ (Hardy, 1992). An ecto­
dermal cue then engulfs the dermal papillae and prompts these epithelial 
cells to differentiate further to develop into a hair follicle, forming a com­
partment of stem cells, a sebaceous gland, and a hair shaft surrounded by 
an outer and inner root sheath (Fig. 3). 
The stem cell compartment is thought to reside in the bulge, just below 
the sebaceous gland. These cells, the dermal papillae and the sebaceous 
gland are permanent fixtures of the follicle. In contrast, the lower two­
thirds of the adult h�ir follicle cycles undergoing periods of growth (an­
agen), rest (catagen), and regression (telogen). Growth appears to be 
dependent upon periodic stimulation of a stem cell by the dermal papilla 
cells. The stem cell is subsequently converted to matrix cells, the transit­
amplifying cells of the hair follicle. These cells proliferate and grow down­
ward, maintaining contact with the papilla. As cells lose contact with 






1.;,,11----- Outer root sheath 
,�;;o----- Inner root sheath 
.....,.,___ _______ Cortex 
•-;__ _______ Matrix 
.__ _______ Dermal papilla 
Fig. 3. The hair follicle. The sebaceous gland, upper outer root sheath (including the 
bulge), and mesenchymally derived dermal papilla are established once, during embryonic 
follicle morphogenesis. The lower portion cycles postnatally by a process involving transient 
stimulation by the dermal papillae of follicle stem cells, thought to reside in the bulge. Ma­
trix cells are transit amplifying cells that differentiate upward in concentric rings of cells, ul­
timately producing the hair shaft and its inner sheath. 
mesenchyme, they choose one of six different programs of terminal differ­
entiation, creating concentric rings of differentiated cell types, which from 
inside to out include: medulla or hair shaft, shaft cuticle, inner root sheath 
cuticle, Henle and Huxley inner root sheath layers, and outer root sheath. 
Each hair that breaks the skin surface is composed of dead cells. The layer 
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of hair shaft cuticle cells encasing the medulla can be visualized by scan­
ning electron microscopy (Fig. 4). 
When matrix cells cease to divide, the catagen period begins. As the 
lower portion of the hair follicle degenerates, the surrounding connec­
tive tissue contracts upward, bringing with it the dermal papilla. The 
papilla then restimulates new stem cells at the base of the permanent 
segment of the follicle (Fig. 3) (Hardy, 1992). Hair cycles can be syn-
Fig. 4. A close-up view of mouse hair. Scanning electron micrograph of mouse hair, il­
lustrating the cellular nature of the hair shaft. The visible outer layer of the shaft is the shaft 
cuticle. Inside are the medulla cells. All of the cells of the hair shaft are dead skelerons, com­
posed largely oflarge cables of hair keratin filaments. Magnification is 12,500X. 
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chronous, as is the first hair cycle of the mouse, which finishes at about 
18 days after birth. In humans, hair cycles are asynchronous, and the 
length of anagen determines the overall length that the hair will achieve. 
For the scalp, each hair grows for 3-5 years, followed by a short catagen 
(about 3 days), followed by a 3-month telogen, culminating in the loss 
of the old hair from the follicle. On average, we lose about 100 hairs per 
day from our scalp. 
Each differentiating layer of cells in the hair follicle expresses a unique 
set of biochemical markers. Similar to the epidermis, the most abundant 
proteins of the hair follicle are the keratins. The Ha and Hb keratin genes 
encode a set of keratins that are only expressed in the differentiating 
cortex cells that give rise to the hair shaft (Powell et al., 1991). In contrast 
to epidermal keratins, the hair-specific keratins are rich in cysteine 
residues, many of which protrude along the surface of the keratin fila­
ments (Powell and Rogers, 1997; Rogers et al., 1997, 1998). Additional 
hair-specific, cysteine-rich proteins interact with the hair keratin fila­
ments to produce larger and more rigid bundles of filaments than are ex­
pressed in the epidermis (Fietz et al., 1993; Fratini et al., 1993). The 
technique involved in a permanent wave at the hair salon takes advantage 
of these facts: after reducing the disulfide bonds in the cytoskeletons of 
the hair shaft cells, the shaft is molded into a curl and the bonds are then 
reformed upon "neutralization." 
Just as there are genetic disorders of keratins that involve the epidermis, 
so are there genetic disorders of the hair keratins and its associated pro­
teins. Monilethrix is a degenerative disorder involving brittle hair in hu­
mans, and not surprisingly it was recently shown to be a disorder 
involving the Ha and Hb keratins (Winter et al., 1997a,b). Similarly, 
transgenic mice displaying perturbations in their hair keratin networks 
display signs of hair brittleness, leading to balding (Powell and Rogers, 
1990). Desmosomal gene defects can also give rise to hair abnormalities: 
expression of a mutant Dsg3 gene in mice causes alterations in the hair 
coat, and a lack of Dsg3 in mice is the cause of a spontaneous recessive 
mouse mutant, given the name "balding" (Koch et al., 1997). Desmoglein 
3 is one of the transmembrane cadherin proteins that is at the core of the 
desmosomes in the basal and suprabasal layers of the epidermis and also in 
the outer root sheath of the hair follicle (Koch et al., 1998; Kurzen et al., 
1998). Presumably, the expression of other desmosomal cadherins in the 
epidermis compensates for the loss of Dsg3 in this tissue. 
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V DEVELOPMENT AND TRANSCRIPTIONAL REGULATION IN THE 
EPIDERMIS: WHAT CONTROLS KERATINOCYTE-SPECIFIC AND 
DIFFERENTIAL PROGRAMMING OF GENE EXPRESSION? 
While much is known about the patterns of expression of structural genes 
in the epidermis and its appendages, much less is known about how these 
patterns are established during development and how the programs of ter­
minal differentiation are orchestrated at the transcriptional level. Epidermal­
specific gene expression has been more extensively studied than hair-specific 
transcription, predominantly because of the ability to culture and transfect 
epidermal keratinocytes in vitro and to simulate terminal differentiation by 
monitoring the levels of calcium in the culture medium. In addition, for 
both basally and suprabasally expressed genes, promoter/enhancer segments 
have been identified that can target epidermal-specific and differentiation­
specific expression of reporter genes in transgenic animals. 
As the study of keratinocyte-specific gene expression progressed, the 
binding sites for three major classes of transcription factors surfaced: AP2, 
Sp 1, and AP 1 (for review, see Byrne, 1997). Where tested, these sites were 
shown to be functionally important for conferring cell type-specific gene 
expression in tissue culture, and they bound factors that were more abun­
dant in keratinocytes than many other cell types (see, e.g., Byrne et al., 
1994; Casatorres et al., 1994; DiSepio et al., 1995; Jang et al., 1996; 
LaPres and Hudson, 1996; Leask et al., 1990, 1991; Snape et al., 1990). 
In addition, a number of mRNAs encoding AP2 or AP 1 family members, 
including AP2a, AP2-y and c-fos, are expressed quite prominently in the 
epidermis and its hair follicles (Byrne et al., 1994; Smeyne et al., 1992). 
Additionally, a number of the transcription factor genes purported to con­
trol basal epidermal-specific gene expression are expressed in early embry­
onic development just prior to the expression of K5 and Kl 4, and at a 
time when the ectoderm is still a single-layered epithelium (Byrne et al., 
1994). Despite these promising correlations, gene knockout studies have 
yet to reveal an unequivocal requirement for any specific AP2, Spl, or 
AP 1 factor in epidermal-specific gene expression. 
Two rather curious and yet nearly universal findings have emerged re­
garding keratinocyte-specific promoters: (1) they contain functional Sp 1, 
AP2, and APl binding sites in the apparent absence of any family mem­
bers that seem to be keratinocyte-specific, and (2) these sites occur in epi­
dermal promoters regardless of the stage in differentiation at which these 
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genes are expressed. The first of these findings raises the question as to 
whether keratinocyte-specific transcription may be achieved through the 
combinatorial action of different members of these transcription factor 
families. The second suggests the possibility that flanking sequences may 
influence the degree to which a specific family member can bind and/ or 
activate the gene. In addition, there could be keratinocyte-restricted or 
preferred co-factors that might interact with and influence the activity of 
these family members. A more complete understanding of the role of these 
and other factors in epidermal-specific and differentiation-specific gene 
expression must await more comprehensive studies exploring in detail the 
activities of multiple epidermal promoters in cultured epidermal cells and 
in transgenic mice. 
VJ. GENE EXPRESSION AND MORPHOGENESIS IN THE HAIR 
FOLLICLE: BALANCING PROLIFERATION AND DIFFERENTIATION 
Elucidating transcriptional regulation in the hair follicle has been ham­
pered by the lack of a culture system capable of inducing hair-specific gene 
expression in vitro and by the complexity of differentiation in the hair fol­
licle. Like the epidermally expressed genes, hair keratin genes often have 
AP2, Sp 1, and AP 1 binding motifs in their promoters (Dunn et al., 1998; 
Powell et al., 1991, 1992). Interestingly, this group of hair-specific pro­
moters also harbors sequence motifs for and binds to the Lefl IT cf family 
of DNA binding proteins (Dunn et al., 1998; Zhou et al., 1995). First 
found as factors involved in lymphoid-specific gene expression (Travis et 
al., 1991; Waterman et al., 1991), Lefl was subsequently shown to be ex­
pressed in developing hair follicles, where its mRNAs first appear in the 
ectodermal placodes that are the sites for follicle morphogenesis (Zhou et 
al., 1995). In vitro organogenesis studies on developing hair follicles and 
teeth suggest that bone morphogenic protein-4 (BMP-4) may be respon­
sible for inducing the expression of Lefl in this fashion (Keranen et al., 
1998; Kratchowil et al., 1996; see also Vainio et al., 1993). 
In the postnatal hair follicle, Lefl mRNA expression is restricted to the 
matrix cells of the postnatal follicle (Gat et al., 1998; Zhou et al., 1995). 
This was surprising since these cells are the precursor cells to the hair ker­
atin-expressing cells. Taken together, the inverse_correlation between Lefl 
expression and hair-specific gene expression in the hair follicle suggest that 
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Lefl might act as an inhibitor for this set of genes. Consistent with this 
notion is the finding that when the Lefl/Tcf site is mutated in a hair ker­
atin promoter, hair-specific gene expression still occurs (Byrne and Fuchs, 
unpublished data; Dunn et al., 1998). 
The expression pattern of Lefl suggests that this factor may play a pos­
itive role earlier in hair follicle morphogenesis. In support of this notion is 
the Lefl knockout mouse, which is notably devoid of whiskers and has se­
vere impairment of body coat hairs (van Genderen et al., 1994). In addi­
tion, overexpression of Lefl driven from the Kl 4 promoter resulted in 
perturbations in the hair coat and the appearance of hairs in inappropriate 
places (Zhou et al., 1995). 
The mysterious role of Lefl as a player in hair follicle formation and 
hair-specific gene expression began to unravel when it was soon recog­
nized that Lefl was the missing factor in the W nt/wingless signal trans­
duction pathway, implicated in many developmental processes (Willert 
and Nusse, 1998). Beta-catenin typically functions only in cadherin­
mediated cell-cell adhesion, and any excess cytoplasmic 13-catenin is 
rapidly degraded through a phosphorylation-dependent, ubiquitin-medi­
ated process (Aberle et al., 1997; Orford et al., 1997). Upon a Wnt signal, 
the GSK3 kinase is inhibited, resulting in the stabilization of 13-catenin 
and its interaction with Lefl/Tcffamily members. Together, the two act as 
a transcription factor with Lefl/Tcf contributing the DNA binding 
domain and 13-catenin supplying the transactivating domain (van de 
Wetering et al., 1997). 
To test the hypothesis that Lefl might function with 13-catenin in hair 
follicle morphogenesis, Gat et al. (1998) expressed a constitutively stable 
form of 13-catenin under the control of the Kl 4 promoter. In this case, ev­
idence of de novo hair follicle morphogenesis was apparent in postnatal 
mouse skin, giving the mice a very furry appearance (Fig. 5). New inter­
follicular invaginations began to appear at about d18. Induced in both in­
terfollicular and outer root sheath cells of the transgenic animals, these de
novo hair germs displayed nuclear Lefl, which by some mechanism, 
presently not clear, was either induced or stabilized in the 13-catenin-acti­
vated cells. The induction of new hair follicle production took place only 
in haired skin regions and seemed coincident with the initiation of the 
first postnatal hair cycle. This has led us to surmise that perhaps the as yet 
unidentified signal(s) transmitted by dermal papillae to instruct existing 
follicles to begin the next hair cycle might also cue to the interfollicular 
Fig. 5. Engineering a furry mouse. A. Transgenic mouse generated by using a basal epidermal keratin 14 (Kl4) promoter to drive the ex­
pression of a stabilized form of f3-catenin (Gat et al., 1998). The engineered form of f3-catenin lacks the normal regulatory machinery of the pro­
tein which would otherwise target any excess cytoplasmic f3-catenin for phosphorylation and ubiquitin-mediated degradation (Aberle et al., 
1996). B. Concrol littermate. 
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transgenic f3-catenin expressing epidermis to initiate the formation of 
brand new follicles. 
Taken together, these recent findings suggest that stabilization of 
f3-catenin in postnatal epidermis results in its conversion to an embryonic 
state, competent to form either epidermis or hair follicles. In other words, 
the ability to stabilize f3-catenin may be a key characteristic of pluripotent 
ectodermal stem cells, and the simultaneous induction of Lefl expression 
by a dermal cue may then commit a stem cell to a hair follicle cell fate. 
The best candidate for a molecule to stabilize f3-catenin is a Wnt family 
member, and in this regard, Wnt 106 (St. Jacques et al., 1998) and 
Wnt 7a (Chuong et al., 1996) have been shown to be expressed in verte­
brate skin. We predict that a characteristic of pluripotent stem cells will be 
Wm-responsiveness, presumably through expression ofWnt receptors. 
Our studies further predict that the activation of f3-catenin-Lefl as a 
transcription factor is key. in converting a follicle stem cell into a transit­
amplifying matrix cell. A clue as to how this might happen stems from the 
recent studies of He et al. (1998), who discovered that c-myc is a down­
stream target gene for f3-catenin/Tcf4 activation in intestinal epithelium. 
N-myc has been shown to be expressed specifically in hair matrix cells
(Sutton et al., 1991), and either N-myc and/or c-myc activation could
readily account for the transient induction of matrix cell proliferation that
occurs during hair morphogenesis in development, and during anagen in
cycling follicles. Intriguingly, members of the myc family have also been
implicated in balancing epidermal proliferation and differentiation
(Hurlin et al., 1995), suggesting the possibility that f3-catenin stabilization
could also be important for converting an epidermal stem cell to a transit­
amplifying cell in the basal layer of the epidermis. If so, we surmise that
another Lef/Tcf family member and/or another f3-catenin co-factor might
be involved, since the only prominent Lefl mRNA detected in postnatal
skin is in the matrix cells of the hair follicle (Gat et al., 1998; Zhou et al.,
1995). The basal layer ceases to express high levels of Lefl mRNAs after
the final sets of hair follicles have been established.
Hair follicle formation requires not only matrix cell proliferation, 
but also remodeling of the intercellular connections within the devel­
oping follicle. This phenomenon could be accounted for if recruitment 
of f3-catenin as a transcription co-factor results in concomitant weak­
ening of those intercellular junctions mediated by f3-catenin. A model 
FASCINATING BIOLOGY OF THE EPIDERMIS AND ITS APPENDAGES 67 
stabilization of 
t3-catenin by Wnt 






Actln ;;,,, .• 
� �t:" BMP4
• cell - cell adhesion
• rapid turnover of excess �cat
• transactivation of
proliferation genes 
• weakening of cell -
cell adhesion 
Fig. 6. Model depicting 13-catenin's roles in hair follicle morphogenesis. Skin epithelium 
begins as a single layer of pluripotent ceUs, able to choose between an epidermal or hair fol­
licle cell fate. A mesenchymal signal(s) cues the ectoderm to initia e a hair follicle. An ecto­
dermal signal then prompts epithelial expansion and the organization and engulfment of a 
specialized dermal condensate, referred to as che dermal papilla. Additional mesenchymal 
cues complete the formation of the hair follicle (for review, see Hardy, 1992). The finding 
that 13-catenin stabilization can cause an adult epidermal cell to act as if it were embryonic 
ectoderm suggests chat a Wm signal is an important external cue to the ectoderm (Gae et al., 
1998). Since Lefl expression occurs in the ectodermal placodes preceding dermal papilla 
formation (Zhou et al., 1995), induction ofLefl by mesenchymal BMP-4 is likely to be a 
second key signal (Kratochwil et al., 1996). Upon stabilization of 13-catenin and accumula­
tion ofLef-1, the ectodermal signal is now generated. This results in the transcriptional ac­
tivation of downstream targets, one of which is myc, known to play a role in hair follicle 
proliferation. Follicle morphogenesis requires both activation of eccodermal proliferation 
and also remodeling of imercellular connections. One possibility is chat 13-cacenin's role in 
these two processes is inversely related, such chat when 13-catenin is recruited as a transcrip­
tion co-factor, it is weakened in its ability to perform at intercellular junctions. Further ex­
periments will be necessary to rest chis hypothesis. (See color places.) 
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summarizing these key points is outlined in Figure 6. While further 
studies will be needed to further test this model, a dual role for 
13-catenin stabilization in both activation of proliferation and inhibi­
tion of cell-cell adhesion poses a compelling argument for why the Wnt
pathway is often implicated in developmental processes involving these
two diverse functions. In support of this notion is the observation that
an N-terminally truncated form of 13-catenin suppresses intercellular
adhesion and tubule formation in cultured MDCK kidney epithelial
cells (Barth et al., 1997; Pollack et al., 1997).
VIL SUM MARY 
A number of fascinating questions remain unaddressed in the realm of 
skin biology. We still know very little about the mechanisms that set up 
the patterning of hair follicles over the surface ectoderm, or about the pre­
cise signalling pathways involved in mesenchymal-epithelial interactions 
during hair development and differentiation. Studies over the past 10 
years have implicated both the notch and sonic hedgehog pathways in these 
processes (Chen et al., 1997; Chiang et al., 1999; Crowe et al., 1998; 
Kopan and Weintraub, 1993; Nohno et al., 1995; Oro and Scott, 1998; 
Powell et al., 1998; St. Jacques et al., 1998). Furthermore, we know that 
members of the fibroblast growth factor and bone morphogenic protein 
families are also involved in mesenchymal-epithelial cues required for fol­
licle morphogenesis, hair cycling, and/or follicle differentiation (Hebert 
et al., 1994; Jung et al., 1998; Kratochwil et al., 1996; Noramly and Mor­
gan, 1998; Rosenquist and Martin, 1996; Song et al., 1996). However, it 
is not clear precisely how these pathways and factors are involved and how 
they might also interact with the wnt pathway in regulating hair follicle 
patterning and morphogenesis. These areas are currently centers of activity 
in the field, and answers will undoubtedly emerge with the flurry of new 
experiments presently being conducted. 
Another important issue is the residence of stem cells within the skin. 
While it is clear that the epidermis contains a population of cells with ex­
traordinary proliferative capacity (Jones and Watt, 1993; Jones et al., 
1995), their precise location in most body regions of the skin remains un­
clear. Similarly, while the bulge hypothesis has received considerable at­
tention and support as the residence of the hair follicle stem cells 
(Cotsarelis et al., 1989; Lavker et al., 1993), the outer root sheath and the 
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matrix of the follicle have also been postulated as potential homes for these 
critical cells (Oliver and Jahoda, 1988; Rochat et al., 1994). An equally 
challenging issue for the future is the extent to which skin stem cells might 
retain pluripotency, able to choose between an epidermal or hair follicle 
cell fate. Our recent studies implicating a Wnt pathway provide a starting 
point for exploration. 
I have discussed a number of recent insights that have surfaced con­
cerning transcriptional regulation in the epidermis. Additionally, besides 
Lefl/f3-catenin, there are a number of transcription factors that have 
been identified that are likely to regulate key aspects of hair follicle dif­
ferentiation and gene expression. The most interesting of these include a 
member, Whn, of the winged-helix transcription factors, recently been 
shown to be the defect underlying the nude mouse phenotype (Nehls et 
al., 1994; Segre et al., 1995) and the zinc finger transcription factor re­
sponsible for the hairless phenotype in mice and in humans (Ahmad et 
al., 1998; Cachon-Gonzalez et al., 1994). A major area for future study 
will be to elucidate the upstream and/or downstream targets of Lefl/ 
f3-catenin, hairless, and whn. 
Let me close by returning to the issues of structure and function in the 
skin and to the underlying genetic basis of skin disorders. It is surprising 
that despite nearly 20 years of molecular genetics and its application to 
skin biology, we still know very little about the molecules and pathways 
involved in the acquisition of the epidermal barrier, the very purpose of 
the epidermis. Biochemical studies have given us clues as to the most im­
portant lipids involved (for review, see Proksch et al., 1993), and recent 
studies suggest that barrier function may in part be regulated through ac­
tion of the steroid hormone superfamily of receptors (Attar et al., 1997; 
Hardman et al., 1998). A major research effort is now needed to begin to 
decipher the transcriptional regulation and the complex pathways in­
volved in lipid synthesis and packaging. Additional emphasis is needed to 
explore how the epidermis shuts down its metabolic activity once the en­
zymes and proteins necessary to create the lipid barrier have been made, 
and then finally, how the lipids are secreted and organized to create the 
Saran Wrap that covers our body surface, protecting us against harmful or­
ganisms from the outside and retaining our bodily fluids. As we face these 
new challenges and begin to unravel the mysteries still kept secret beneath 
the beauty of the skin, new insights will emerge not only into the biology 
of the skin but also into its genetic diseases. 
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